Keywords: implications, emerging, indian, pharmaceutical, sector, ms, analysts
Implications from emerging Indian pharmaceutical sector; MS analysts' view
Article | 17 November 2003
The Indian pharmaceutical industry generated turnover of around $6billion in 2002 and is expected to grow revenues and profits at 13% and 17%, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
